Concepedia

Zhengyang Hao

ZH

Statistics

Publications

5

Citations

119

H-Index

5

Active since

2021

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengyang Hao is an author at First Affiliated Hospital of Zhengzhou University specializing in life sciences, signal transduction, and molecular biology.

Publications per year

2021–2022

5

Publications

5

OTUB1 alleviates NASH through inhibition of the TRAF6‐ASK1 signaling pathways

Jielei Zhang, Binbin Du, Dianhong Zhang et al. · Hepatology · 2021 · 40 citations

, , +16

E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING

Wenchang Xiao, Huan Li, Zhengyang Hao et al. · Cell Death and Disease · 2022 · 33 citations · Full text

, , +17

Runt‐related transcription factor 1 (Runx1) aggravates pathological cardiac hypertrophy by promoting p53 expression

Dianhong Zhang, Cui Liang, Pengcheng Li et al. · Journal of Cellular and Molecular Medicine · 2021 · 23 citations · Full text

, , +16

Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study

Zhengyang Hao, Yanzhou Zhang · International Journal of General Medicine · 2022 · 13 citations · Full text

, , +16

Different Doses of Empagliflozin in Patients with Heart Failure with Reduced Ejection Fraction

Zhengyang Hao, Yanzhou Zhang · International Heart Journal · 2022 · 10 citations · Full text

, , +16

1–5 of 5